Archives
Human SAN-Plexus Assembloids Model Pacemaker Maturation
2026-06-12
Modeling Human Pacemaker Maturation with PSC-Derived SAN-Plexus Assembloids
Study Background and Research Question
The sinoatrial node (SAN) acts as the heart’s primary pacemaker, initiating the electrical impulses that orchestrate cardiac rhythm. The complex interplay between SAN pacemaker cells, surrounding atrial myocardium, and intrinsic cardiac neural networks underpins both normal heart function and arrhythmogenesis. While animal studies have elucidated key principles of SAN formation and neural regulation, translation to human systems is limited by interspecies differences and the inaccessibility of human SAN tissue. Human pluripotent stem cell (hPSC) differentiation and cardiac organoid technologies have advanced, yet existing models fail to recapitulate the three-dimensional (3D) architecture and neuro-cardiac interactions essential for studying pacemaker development and disease.The central question addressed in the reference study is: Can advanced assembloid systems, integrating human SAN and cardiac plexus organoids, faithfully model the innervation-associated maturation of the pacemaker system and its regulation by neural inputs?
Key Innovation from the Reference Study
The landmark innovation of this work is the development of a tri-assembloid system that brings together human PSC-derived SAN organoids (SANOs), cardiac ganglionated plexus organoids (CGPOs), and atrial-like cardiac organoids. This configuration enables, for the first time, a functional in vitro model that recapitulates the molecular, structural, and electrophysiological hallmarks of human pacemaker activity and its modulation by intrinsic neural elements.Crucially, the study integrates spatial transcriptomics from native human SAN tissue with assembloid-based functional interrogation. This dual approach uncovers a neuron-to-pacemaker signaling program, exemplified by CGPO-derived prosaposin (PSAP) signaling through the GPR37 receptor, which is enriched in the SAN and shown to promote pacemaker maturation.
Methods and Experimental Design Insights
The experimental workflow is characterized by several methodological advances:- Generation of component organoids: Human PSCs are differentiated into SANOs, CGPOs, and atrial-like organoids using stage-specific growth factors and small molecules, recapitulating key aspects of cardiac and neural lineage specification.
- Tri-assembloid assembly: The three organoid types are combined in defined spatial configurations, allowing for the study of pacemaker-to-atrial conduction and neural modulation within a 3D context.
- Electrophysiological assessment: The assembloids are evaluated for spontaneous electrical activity, conduction velocity, and response to pharmacological manipulation, providing insight into functional maturation and disease modeling.
- Spatial transcriptomics: High-resolution transcriptomic mapping of human SAN tissue enables direct comparison and validation of assembloid gene expression and cellular heterogeneity.
- Functional interrogation of signaling pathways: Gain- and loss-of-function approaches are used to probe the role of neuron-derived factors, such as PSAP-GPR37 signaling, in SAN maturation.
Protocol Parameters
- SAN organoid induction: Sequential exposure to cardiac mesoderm and pacemaker lineage cues, typically over 10–15 days.
- Cardiac plexus organoid derivation: Neural crest induction and aggregation protocols spanning 7–10 days before combination with SAN organoids.
- Tri-assembloid assembly: Co-culture of SANOs, CGPOs, and atrial organoids in defined ratios (e.g., 1:1:1) on low-adhesion substrates for 3–5 days prior to functional analysis.
- Electrophysiological readouts: Patch-clamp and optical mapping to assess spontaneous pacemaker activity, conduction, and autonomic responsiveness.
- Beta-adrenergic stimulation (practical recommendation): When investigating beta-adrenergic receptor signaling or cAMP/PKA pathway activation, isoproterenol hemisulfate is frequently used at concentrations of 0.1–10 μM, with precise dosing tailored to organoid maturity and experimental objectives.
Core Findings and Why They Matter
The tri-assembloid platform displays several cardinal features of the human pacemaker system:- 3D cytoarchitecture: The assembloids recapitulate the spatial organization and cellular heterogeneity of the human SAN, including head, tail, and transitional pacemaker cell populations.
- Functional conduction: Electrophysiological recordings demonstrate spontaneous diastolic depolarization, slow upstroke action potentials, and robust pacemaker-to-atrial conduction, mirroring human physiology.
- Neural control: The presence of CGPO-derived neurons modulates SAN automaticity, shifting pacemaker dominance and firing rate in response to simulated autonomic input—critical for modeling both normal and diseased states.
- PSAP-GPR37 signaling: The study identifies a neuron-to-pacemaker pathway in which prosaposin released from cardiac plexus neurons activates GPR37 on SAN cells, promoting the maturation of pacemaker function.
- Disease modeling: Disruption of neuro-cardiac signaling in the assembloid context induces conduction abnormalities reminiscent of congenital SAN dysfunction, highlighting translational relevance.
Comparison with Existing Internal Articles
Several recent reviews and workflow-focused articles converge on the importance of precise beta-adrenergic modulation in human pacemaker models:- The article "Isoproterenol Sulfate Dihydrate: Advancing Human Pacemaker Models" highlights how Isoproterenol sulfate dihydrate enables rigorous study of beta-adrenergic receptor signaling and cAMP/PKA pathway activation in stem cell-derived cardiac systems, complementing the assembloid approach by providing practical protocol guidance.
- "Modeling Human Pacemaker Maturation with SAN-Plexus Assembloids" provides an accessible overview of the tri-assembloid system, emphasizing its value for dissecting neuro-cardiac interactions and conduction disorders. This aligns with the reference study’s demonstration of neuron-to-pacemaker signaling and functional maturation.
- For researchers prioritizing workflow reproducibility, "Isoproterenol sulfate dihydrate: Reliable Beta-Adrenergic Signaling in Human Cell Models" discusses technical considerations in compound solubility, stability, and data interpretation when using isoproterenol hemisulfate in cell-based cardiovascular assays.
Limitations and Transferability
Despite its sophistication, the tri-assembloid model has several limitations:- Developmental maturity: While the system achieves key features of pacemaker maturation, it may not fully recapitulate the adult human SAN or long-term remodeling dynamics.
- Complexity and scalability: The assembly process requires precise timing, expertise in stem cell differentiation, and may present challenges for high-throughput adaptation.
- Physiological fidelity: Certain aspects of autonomic regulation and systemic cardiovascular responses remain difficult to model ex vivo, necessitating cautious interpretation when extrapolating to in vivo human physiology.